Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms
Open Access
- 21 July 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (8), 1546
- https://doi.org/10.3390/microorganisms9081546
Abstract
The relatively high post-treatment relapse rates of paromomycin (PMM) in visceral leishmaniasis treatment and the swift emergence of experimental drug resistance challenge its broad application and urge for rational use and monitoring of resistance. However, no causal molecular mechanisms to Leishmania PMM resistance have been identified so far. To gain insights into potential resistance mechanisms, twelve experimentally selected Leishmania donovani clonal lines and the non-cloned preselection population, with variable degrees of PMM resistance, were subjected to whole genome sequencing. To identify genomic variations potentially associated with resistance, SNPs, Indels, chromosomal somy and gene copy number variations were compared between the different parasite lines. A total of 11 short nucleotide variations and the copy number alterations in 39 genes were correlated to PMM resistance. Some of the identified genes are involved in transcription, translation and protein turn-over (transcription elongation factor-like protein, RNA-binding protein, ribosomal protein L1a, 60S ribosomal protein L6, eukaryotic translation initiation factor 4E-1, proteasome regulatory non-ATP-ase subunit 3), virulence (major surface protease gp63, protein-tyrosine phosphatase 1-like protein), mitochondrial function (ADP/ATP mitochondrial carrier-like protein), signaling (phosphatidylinositol 3-related kinase, protein kinase putative and protein-tyrosine phosphatase 1-like protein) and vesicular trafficking (ras-related protein RAB1). These results indicate that, in Leishmania, the aminoglycoside PMM affects protein translational processes and underlines the complex and probably multifactorial origin of resistance.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (G051812N, G013118N and 12I0317N)
- University of Antwerp (TT-ZAPBOF 33049 and TOP-BOF 35017)
- Wellcome Trust (Seed Award in Science 208965/Z/17/Z)
This publication has 56 references indexed in Scilit:
- Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection ProtocolPLoS Neglected Tropical Diseases, 2012
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing dataBioinformatics, 2011
- The variant call format and VCFtoolsBioinformatics, 2011
- Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding StudyPLoS Neglected Tropical Diseases, 2010
- Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized TrialPLoS Neglected Tropical Diseases, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- TriTrypDB: a functional genomic resource for the TrypanosomatidaeNucleic Acids Research, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Paromomycin: Uptake and resistance in Leishmania donovaniMolecular and Biochemical Parasitology, 2009